Use of plasma volume substitutes and plasma in developing countries*
Lundsgaard-Hansen, P., Collins, J. A., David-West, A. S., Lopez, C. G., Hantchef, Z. S. et al. (1983). Use of plasma volume substitutes and plasma in developing countries*. Bulletin of the World Health Organization, 61 (1), 7 - 22. http://www.who.int/iris/handle/10665/264834
JournalBulletin of the World Health Organization, 61 (1): 7 - 22
MetadataShow full item record
Showing items related by title and MeSH subject.
Message from, Dr Hussein A. Gezairy, Regional Director, WHO Eastern Mediterranean Region, to the regional consultation for quality assurance, and safety of plasma and plasma derivatives, Cairo, Egypt, 31 January-3 February 2005 World Health Organization, Regional Office for the Eastern Mediterranean (2005)
Effect of quinine therapy on plasma glucose and plasma insulin levels in pregnant women infected with Plasmodium falciparum malaria in Gezira state Elbadawi, N.E.E.; Mohamed, M.I.; Dawod, O.Y.; Ali, K.E.; Daoud, O.H.; Ali, E.M.; Ahmed, E.G.E.; Mohamed, A.E. (2011)To determine if quinine has a metabolic effect during treatment of severe or complicated malaria, we studied its effects on plasma glucose and plasma insulin levels in 150 pregnant women with malaria referred to Madani maternity teaching hospital, Gezira state and 50 healthy pregnant controls. Levels were determined at baseline [day 0] before the start of quinine treatment, after 2 days of treatment [2 hours after the 4th dose] and after 7 days of treatment [day 8]. There was a statistically significant increase in plasma insulin concentrations ...
WHO Global Programme on AIDS; League of Red Cross Societies; Global Blood Safety Initiative; World Health Organization. Health Laboratory Technology Unit (WHO/GPA/INF/89.17WHO/LAB/89.9. Unpublished, 1989)